The price of MED is predicted to go up 2.99%, based on the high correlation periods with COLM. The similarity of these two price pattern on the periods is 93.44%.
MED
COLM
Up: 2.99%Similarity: 93.44%
MED Revenue Forecast
MED EPS Forecast
MED FAQs
What is MED revenue forecast for next quarter?
The market consensus for MED's revenue in the upcoming quarter is projected to be approximately $114.85M USD.
What is MED eps forecast for next quarter?
The market consensus for MED's eps in the upcoming quarter is projected to be approximately $0.29 USD.
DA Davidson analyst Linda Bolton Weiser upgraded Medifast to Neutral from Underperform with a price target of $17, up from $16.50. With cash and investments of about $15.50 per share and no debt, the valuation "already seems to imply near zero for the remaining declining business," so share price downside could be more limited from here, the analyst tells investors.